KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueLiabilities and Shareholders EquityLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Oscar Health (OSCR) Short-term Investments (2020 - 2025)

Oscar Health (OSCR) has disclosed Short-term Investments for 6 consecutive years, with $1.2 billion as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Short-term Investments rose 94.8% year-over-year to $1.2 billion, compared with a TTM value of $1.2 billion through Dec 2025, up 94.8%, and an annual FY2025 reading of $1.2 billion, up 94.8% over the prior year.
  • Short-term Investments was $1.2 billion for Q4 2025 at Oscar Health, up from $887.6 million in the prior quarter.
  • Across five years, Short-term Investments topped out at $1.4 billion in Q4 2022 and bottomed at $363.6 million in Q2 2024.
  • Average Short-term Investments over 5 years is $811.4 million, with a median of $734.9 million recorded in 2022.
  • The sharpest move saw Short-term Investments plummeted 71.04% in 2024, then soared 157.98% in 2025.
  • Year by year, Short-term Investments stood at $587.1 million in 2021, then soared by 138.0% to $1.4 billion in 2022, then crashed by 50.63% to $689.8 million in 2023, then fell by 9.48% to $624.5 million in 2024, then surged by 94.8% to $1.2 billion in 2025.
  • Business Quant data shows Short-term Investments for OSCR at $1.2 billion in Q4 2025, $887.6 million in Q3 2025, and $938.1 million in Q2 2025.